400899-84-5

Basic information

• Product Name: Carbamic acid, methyl(4-oxocyclohexyl)-, 1,1-dimethylethyl ester
• Synonyms: Carbamic acid, methyl(4-oxocyclohexyl)-, 1,1-dimethylethyl ester;4-(N-Boc-N-methylamino)cyclohexanone;CarbaMic acid, N-Methyl-N-(4-oxocyclohexyl)-, 1,1-diMethylethyl ester;tert-butyl N-Methyl-N-(4-oxocyclohexyl)carbaMate;N-methyl-N-(4-oxocyclohexyl)Carbamic acid 1,1-dimethylethyl ester;tert-Butyl methyl(4-oxocyclohexyl)
• CAS NO: 400899-84-5
• Molecular Formula: C12H21NO3
• Molecular Weight: 227.30004
• Mol File: 400899-84-5.mol

Chemical Properties

• Boiling Point: 316.6 °C at 760 mmHg
• Flash Point: 145.3 °C
• Appearance: /
• Density: 1.05 g/cm³
• Vapor Pressure: 0.000407mmHg at 25°C
• Refractive Index: 1.48
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: -1.45±0.20(Predicted)
• CAS DataBase Reference: Carbamic acid, methyl(4-oxocyclohexyl)-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, methyl(4-oxocyclohexyl)-, 1,1-dimethylethyl ester(400899-84-5)
• EPA Substance Registry System: Carbamic acid, methyl(4-oxocyclohexyl)-, 1,1-dimethylethyl ester(400899-84-5)

Safety Data

• Hazardous Substances Data: 400899-84-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Carbamic acid, methyl(4-oxocyclohexyl)-, 1,1-dimethylethyl ester is used as an intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the formation of complex molecular structures that can exhibit therapeutic effects.
Used in Agrochemical Industry:
In the agrochemical sector, this ester derivative is utilized in the production of compounds that can be integrated into pesticides or other agricultural chemicals, leveraging its reactivity and structural features to enhance the effectiveness of these products.
Used in Organic Chemistry Research:
Carbamic acid, methyl(4-oxocyclohexyl)-, 1,1-dimethylethyl ester serves as a key component in organic chemistry research, where its unique properties are explored for the development of new reactions or to understand its behavior in various chemical contexts.

InChI:InChI=1/C12H21NO3/c1-12(2,3)16-11(15)13(4)9-5-7-10(14)8-6-9/h9H,5-8H2,1-4H3

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 2976-84-3 4-methylaminocyclohekxanone 
• 4746-97-8 cyclohexanedione monoethylene ketal 

Downstream Products

• 1415813-02-3 tert-butyl N-methyl-N-(4-methylenecyclohexyl)carbamate 

Relevant articles and documents

DI-SUBSTITUTED AMIDES FOR ENHANCING GLUTAMATERGIC SYNAPTIC RESPONSES

This invention relates to compounds, pharmaceutical compositions and methods for use in the prevention and treatment of cerebral insufficiency, including enhancement of receptor functioning in synapses in brain networks responsible for basic and higher order behaviors. These brain networks, which are involved in regulation of breathing, and cognitive abilities related to memory impairment, such as is observed in a variety of dementias, in imbalances in neuronal activity between different brain regions, as is suggested in disorders such as Parkinson's disease, schizophrenia, respiratory depression, sleep apneas, attention deficit hyperactivity disorder and affective or mood disorders, and in disorders wherein a deficiency in neurotrophic factors is implicated, as well as in disorders of respiration such as overdose of an alcohol, an opiate, an opioid, a barbiturate, an anesthetic, or a nerve toxin, or where the respiratory depression results form a medical condition such as central sleep apnea, stroke- induced central sleep apnea, obstructive sleep apnea, congenital hypoventilation syndrome, obesity hypoventilation syndrome, sudden infant death syndrome, Rett syndrome, spinal cord injury, traumatic brain injury, Cheney-Stokes respiration, Ondines curse, Prader-Willi's syndrome and drowning. In a particular aspect, the invention relates to compounds useful for treatment of such conditions, and methods of using these compounds for such treatment.